Barriers to overcoming immunotherapy resistance in glioblastoma

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, known for its poor prognosis and high recurrence rate. Current standard of care includes surgical resection followed by combined radiotherapy and chemotherapy. Although immunotherapies have yielded promising results in h...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillette, Julia S., Wang, Elaina J., Dowd, Richard S., Toms, Steven A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232794/
https://www.ncbi.nlm.nih.gov/pubmed/37275361
http://dx.doi.org/10.3389/fmed.2023.1175507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232794/
https://www.ncbi.nlm.nih.gov/pubmed/37275361
http://dx.doi.org/10.3389/fmed.2023.1175507

Ejemplares similares